title: Carcinoembryonic antigen-related cell adhesion molecule (CEACAM)-binding recombinant polypeptide confers protection against infection by respiratory and urogenital pathogens.
abstract: The human-specific pathogens Neisseria meningitidis, N. gonorrhoea, Haemophilus influenzae and Moraxella catarrhalis share the property of targeting the carcinoembryonic antigen (CEA)-related cell adhesion molecules (CEACAMs) expressed on human epithelia. CEACAMs are signalling receptors implicated in cell adhesion and regulation of several physiological functions. Their targeting by pathogens can lead to tissue invasion. Although the CEACAM-binding ligands of the bacteria are structurally diverse, they target a common site on the receptor. We have generated a recombinant polypeptide that blocks the interactions of the mucosal pathogens with human epithelial cells and antibodies against it inhibit M. catarrhalis interactions with the receptor. As such, it is a potential antimicrobial agent to prevent infection via a strategy unlikely to promote bacterial resistance and a vaccine candidate against M. catarrhalis. In addition, it could serve more widely as a novel research tool and as a potential therapeutic agent in CEACAM-based physiological disorders.
authors.affiliation: Department of Pathology and Microbiology, University of Bristol, Bristol, BS8 1TD, UK.
authors.forename: Darryl J
authors.initials: DJ
authors.lastname: Hill
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Edwards
authors.forename: Helen A
authors.initials: HA
authors.lastname: Rowe
authors.forename: Mumtaz
authors.initials: M
authors.lastname: Virji
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000378:metabolism*; D000943:Antigens, Differentiation / Q000378:metabolism*; D001422:Bacterial Adhesion / Q000502:physiology*; D016466:CHO Cells; D015815:Cell Adhesion Molecules; D006224:Cricetinae; D052776:Female Urogenital Diseases / Q000517:prevention & control; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism*; D052801:Male Urogenital Diseases; D001936:Moraxella catarrhalis / Q000472:pathogenicity / Q000502:physiology; D011956:Receptors, Cell Surface / Q000378:metabolism*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000517:prevention & control
chemical_list: D015703:Antigens, CD; D000943:Antigens, Differentiation; C069847:CD66 antigens; D015815:Cell Adhesion Molecules; D011956:Receptors, Cell Surface; D011994:Recombinant Proteins